Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABOBOTULINUMTOXINA Cause Intentional product use issue? 70 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Intentional product use issue have been filed in association with ABOBOTULINUMTOXINA. This represents 1.2% of all adverse event reports for ABOBOTULINUMTOXINA.

70
Reports of Intentional product use issue with ABOBOTULINUMTOXINA
1.2%
of all ABOBOTULINUMTOXINA reports
0
Deaths
5
Hospitalizations

How Dangerous Is Intentional product use issue From ABOBOTULINUMTOXINA?

Of the 70 reports, 5 (7.1%) required hospitalization.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABOBOTULINUMTOXINA. However, 70 reports have been filed with the FAERS database.

What Other Side Effects Does ABOBOTULINUMTOXINA Cause?

Off label use (2,271) Drug ineffective (1,677) Product preparation error (751) Headache (379) Overdose (344) Inappropriate schedule of drug administration (318) Therapeutic response shortened (313) Eyelid ptosis (301) Injection site pain (278) Muscular weakness (272)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which ABOBOTULINUMTOXINA Alternatives Have Lower Intentional product use issue Risk?

ABOBOTULINUMTOXINA vs ABRAXANE ABOBOTULINUMTOXINA vs ABROCITINIB ABOBOTULINUMTOXINA vs ACALABRUTINIB ABOBOTULINUMTOXINA vs ACAMPROSATE ABOBOTULINUMTOXINA vs ACARBOSE

Related Pages

ABOBOTULINUMTOXINA Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue ABOBOTULINUMTOXINA Demographics